Trials / Completed
CompletedNCT02812979
Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified
Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified Compared to a Usual Method
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The principal objective is to show noninferiority of nebulized salbutamol through the high flow nasal system moistened AIRVO ™ 2 in terms of reversibility of airflow obstruction compared to nebulization by the usual method (spray mask).
Detailed description
Randomized, comparative, non inferiority study between two nebulization strategies bronchodilators, one according to the method tested namely the spray - in across the top humidified nasal flow system and the other according to a customary procedure, through a mask. A third arm will be evaluated (control arm) to overcome a possible own bronchodilator effect of high flow nasal humidified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Airvo2 with Aerogen Solo | Nebulization of salbutamol with Airvo 2 and Aerogen solo |
| DEVICE | Mask | Usual nebulization of salbutamol with mask |
| DEVICE | arm control Airvo2 without nebulization of salbutamol | Airvo2 with Aerogen Solo. No nebulization of salbutamol |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-04-27
- Completion
- 2018-04-27
- First posted
- 2016-06-24
- Last updated
- 2025-12-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02812979. Inclusion in this directory is not an endorsement.